The step-by-step history
|1984||Creation of a microsurgery service company by Christian Lecomte.|
Development of the first forceps for cardiac biospies by Professor Cabrol.
|1993||Founding of the DB2C company by Michel Duvemois and Jean-Luc Bluet.|
The rapidly gained confidence in DB2C of many surgeons facilitated the marketing of a large range of instruments for professionals, especially within fields such as laparoscopy and cardiology.
|1996||First export of cardiac biopsy forceps to Japan.|
|1997||First CE mark for the cardiac biopsy forceps and laparoscopy forceps.|
|2009||Acquisition of DB2C by ab medica, a company presided by Aldo Cerruti whose primary aim is innovation of services to improve quality of care.|
|2010||Granted ISO 13485 Certification for the production and distribution of medical devices.|
|2011||Granted ISO 13485 Certification for the design, production and distribution of medical devices.|
|2013||Creation of a new range of instruments for microlaparoscopy.|
|2014||First FDA approval for the range of microlaparoscopic instruments.|
The wide range of microlaparoscopy instruments enables scarless surgery, while maintaining essential characteristics such as stiffness of the surgical instrument, non-traumatic grip of tissues and precision of movement control. This affords the operator a high quality clinical performance and an excellent aesthetic outcome for the patient.
The large range of products is distinguished by:
ab medica s.a.s.
les Petites Quarterees
Tel. +33 (0)2 48515993